10x Genomics Inc (TXG)

10x Genomics (TXG) Financial Statements


10x Genomics Financial Overview

10x Genomics's market cap is currently ―. The company's EPS TTM is $-1.46; its P/E ratio is -34.40; 10x Genomics is scheduled to report earnings on May 3, 2023, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 156.23M$ 131.07M$ 114.61M$ 114.50M$ 143.53M
Gross Profit$ 119.41M$ 100.69M$ 86.91M$ 89.02M$ 115.93M
EBIT$ -16.29M$ -39.92M$ -63.72M$ -41.57M$ -15.78M
EBITDA$ -7.81M$ -31.81M$ -55.28M$ -33.59M$ -8.45M
Net Income Common Stockholders$ -17.21M$ -41.91M$ -64.46M$ -42.41M$ -18.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 429.98M$ 452.39M$ 499.73M$ 539.32M$ 587.45M
Total Assets$ 1.03B$ 996.21M$ 1.00B$ 1.00B$ 1.02B
Total Debt$ 95.18M$ 96.23M$ 99.02M$ 101.17M$ 81.98M
Net Debt$ -334.81M$ -356.16M$ -400.72M$ -438.15M$ -505.47M
Total Liabilities$ 223.24M$ 220.41M$ 218.07M$ 196.57M$ 201.26M
Stockholders Equity$ 805.74M$ 775.79M$ 783.52M$ 806.68M$ 817.57M
Cash Flow-
Free Cash Flow$ -26.01M$ -46.14M$ -44.18M$ -48.94M$ -21.81M
Operating Cash Flow$ 13.72M$ -9.56M$ -16.96M$ -20.80M$ 5.80M
Investing Cash Flow$ -33.17M$ -32.63M$ -27.53M$ -257.56M$ -27.62M
Financing Cash Flow$ 5.00M$ 2.04M$ 6.36M$ 2.42M$ 8.90M
Currency in USD

10x Genomics Earnings and Revenue History

10x Genomics Debt to Assets

10x Genomics Cash Flow

10x Genomics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis